Genetic association of lipid and lipid-lowering drug target genes with atopic dermatitis: a drug target Mendelian randomization study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Genetic association of lipid and lipid-lowering drug target genes with atopic dermatitis: a drug target Mendelian randomization study ; volume:14 ; number:1 ; day:5 ; month:8 ; year:2024 ; pages:1-10 ; date:12.2024
Scientific reports ; 14, Heft 1 (5.8.2024), 1-10, 12.2024
- Creator
-
Niu, Qinwang
Zhang, Tongtong
Mao, Rui
Zhao, Nana
Deng, Sui
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-69180-2
- URN
-
urn:nbn:de:101:1-2410252129595.088551378607
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Niu, Qinwang
- Zhang, Tongtong
- Mao, Rui
- Zhao, Nana
- Deng, Sui
- SpringerLink (Online service)
Other Objects (12)
Correlations between genetically predicted lipid-lowering drug targets and inflammatory bowel disease
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Causal relationship between lipid-lowering drugs and ovarian cancer, cervical cancer: a drug target mendelian randomization study
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Association of lipid-lowering drug targets with risk of cutaneous melanoma: a mendelian randomization study
Association of lipid-lowering drugs with risk of sarcopenia: a drug target mendelian randomization study and meta-analysis
Effects of Lipid-Lowering Drugs Upon Fasting-Induced Platelet Aggregation
Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
Genetic association of lipids and lipid lowering drug target genes with sarcoidosis
Effective policy initiatives to constrain lipid-lowering drug expenditure growth in South Korea
Metabolomics approach reveals effects of antihypertensives and lipid-lowering drugs on the human metabolism
Correlations between genetically predicted lipid-lowering drug targets and inflammatory bowel disease
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Causal relationship between lipid-lowering drugs and ovarian cancer, cervical cancer: a drug target mendelian randomization study
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Association of lipid-lowering drug targets with risk of cutaneous melanoma: a mendelian randomization study
Association of lipid-lowering drugs with risk of sarcopenia: a drug target mendelian randomization study and meta-analysis
Effects of Lipid-Lowering Drugs Upon Fasting-Induced Platelet Aggregation
Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
Genetic association of lipids and lipid lowering drug target genes with sarcoidosis
Effective policy initiatives to constrain lipid-lowering drug expenditure growth in South Korea
Metabolomics approach reveals effects of antihypertensives and lipid-lowering drugs on the human metabolism
Correlations between genetically predicted lipid-lowering drug targets and inflammatory bowel disease
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Causal relationship between lipid-lowering drugs and ovarian cancer, cervical cancer: a drug target mendelian randomization study
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Association of lipid-lowering drug targets with risk of cutaneous melanoma: a mendelian randomization study
Association of lipid-lowering drugs with risk of sarcopenia: a drug target mendelian randomization study and meta-analysis
Effects of Lipid-Lowering Drugs Upon Fasting-Induced Platelet Aggregation
Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
Genetic association of lipids and lipid lowering drug target genes with sarcoidosis
Effective policy initiatives to constrain lipid-lowering drug expenditure growth in South Korea